Newsroom

Latest news, updates,
announcements, media & events.

Firm Updates

18

MAY 2022

Regencor Announces New CEO

26

APR 2022

BioEclipse Therapeutics™ Awarded Almost $8M Grant by CIRM to Fund Ongoing Phase 1 CRX100 Cancer Immunotherapy Clinical Trial

28

JAN 2022

BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

21

JAN 2022

Allogene Therapeutics Announces Exclusive Collaboration and Global License Agreement with Antion Biosciences for Multiplex miCAR Technology

29

NOV 2021

CIRM awards $3.9M to Regencor for development of wearable injector treatment for cardiac regeneration

28

OCT 2021

Travera raises $5.5M Series A Extension led by Khosla Ventures

19

MAY 2021

Nodes Advisors invited to attend the 2021 Virtual World Medical Innovation Forum: Gene and Cell Therapy

28

FEB 2020

Sensulin to appoint Nodes Advisors as exclusive advisors for its Series A.

02

FEB 2020

Nodes Advisors selected to speak at the Festival Biologics 2020 Conference in Basel

04

MAY 2020

Regencor to appoint Nodes Advisors as exclusive advisors for its Series A round